Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

(NASDAQ:AVXL), NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it will present […]

Revival Gold Delivers Compelling PEA Results and Attractive Potential Re-development Timeline for the Mercur Gold Project

(TSX-V:RVG),(OTC US:RVLGF),(Other OTC:RVLGF), TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce compelling results from a Preliminary Economic Assessment (“PEA”) on the Company's Mercur Gold Project (“Mercur” or the “Project”) in Utah, U.S.A. Furthermore, the Project's favorable mineral tenure, straightforward design

Hoplon Capital Announces Formation of Vistina Structured Credit and Inaugural Structured Finance Advisory Mandate

$1.35 billion first-ever securitization of internet identity services assets Hoplon Capital LLC (“Hoplon”), a financial services holding company, is pleased to announce both the formation of Vistina Structured Credit, LLC (“Vistina”) and the completion of Vistina's inaugural structured financing advisory mandate. Vistina is led by experienced structured finance professionals Robert Horowitz and Peter Forshee, both

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

Isomorphic Labs will utilise the funding to further power its AI drug designengine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding round. The financing round is led

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR(R) THV

(AUST:AVR.AX),(NasdaqGM:AVR), MINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (Anteris(R) or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices, announces a significant milestone in our mission to restore heart valve patients to healthy function. Our first in class,

Sapiens Life Platform Selected by a Leading U.S. Insurer

Sapiens' solutions accelerate insurer's seamless, data-driven digital transformation Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced that a major U.S. multi-line insurer has expanded its partnership with Sapiens by selecting Sapiens Insurance Platform for Life & Annuities, which includes Sapiens CoreSuite for Life

L3Harris’ Commercial Aviation Solutions (CAS) Business, now known as Acron Aviation

ST. PETERSBURG, Fla., March 31, 2025 (GLOBE NEWSWIRE) — Today, L3Harris Commercial Aviation Solutions (CAS) will be known as Acron Aviation to reflect its new brand following the acquisition of the business by TJC LP. The new name is adapted from the Greek word άkron which means peak, or highest point and aptly symbolizes the

Ingersoll Rand Recommends Rejection of TRC Capital’s “Mini-Tender” Offer

(NYSE:IR), DAVIDSON, N.C., March 31, 2025 (GLOBE NEWSWIRE) — Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced that it received notice of an unsolicited “mini-tender” offer by TRC Capital Investment Corporation (TRC Capital) to purchase up to 1,500,00 shares of Ingersoll Rand's common

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

(NasdaqGM:APLT), NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities

7-Eleven, Inc. and Laredo Taco Company® Spice Up National Burrito Day with a Flavor Fiesta

Celebrate the day with a sizzling $5 offer and all-new shrimp burritos Burrito lovers, rejoice! National Burrito Day is just around the corner, and 7-Eleven®,Speedway®andStripes®stores are dishing out mouthwatering deals to celebrate. OnApril 3, customers can savor flavorful burritos for an irresistible price at just $5 from Laredo Taco Company®. https://mma.prnewswire.com/media/2653064/chicken_fajita_asset.jpg Customers can celebrate with

Scroll to Top